People
Brígida R. Pinho
senior researcher
Research Group
Position
Assistant Researcher (Permanent contract) (since 2025)
Email
brpinho@ff.up.pt
ORCID
Ciência Vitae
Recent publications
- Oliveira, NAS; Pinho, BR; Pinto, J; de Pinho, PG; Oliveira, JMA. 2024. Edaravone counteracts redox and metabolic disruptions in an emerging zebrafish model of sporadic ALS. FREE RADICAL BIOLOGY AND MEDICINE, 217, DOI: 10.1016/j.freeradbiomed.2024.03.016
- Pinho, BR; Duarte, AI; Canas, PM; Moreira, PI; Murphy, MP; Oliveira, JMA. 2020. The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice. FREE RADICAL BIOLOGY AND MEDICINE, 146, DOI: 10.1016/j.freeradbiomed.2019.11.021
- Pinho, BR; Reis, SD; Hartley, RC; Murphy, MP; Oliveira, JMA. 2019. Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells. FREE RADICAL BIOLOGY AND MEDICINE, 130, DOI: 10.1016/j.freeradbiomed.2018.10.446
- Soares, TR; Reis, SD; Pinho, BR; Duchen, MR; Oliveira, JMA. 2019. Targeting the proteostasis network in Huntington's disease. AGEING RESEARCH REVIEWS, 49, DOI: 10.1016/j.arr.2018.11.006
- Reis, SD; Pinho, BR; Oliveira, JMA. 2017. Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders. MOLECULAR NEUROBIOLOGY, 54, DOI: 10.1007/s12035-016-0120-z
- Pinho, BR; Santos, MM; Fonseca-Silva, A; Valentao, P; Andrade, PB; Oliveira, JMA. 2013. How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs. BRITISH JOURNAL OF PHARMACOLOGY, 169, DOI: 10.1111/bph.12186